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• Meets application 




Strain, fermentation, process engineering → deliver BEP































































































































































Strain Design and Commercial Strain for
and Engineering Metabolic Engineering BDO Production
• Titer (g/L) - Impacts equipment sizing and energy needs
• Rate (g/L/h) - Impacts # of fermentors, plant capacity
• Yield (g/g) - Impacts feedstock cost contribution
Fermentation Metrics → Higher TRY = Lower COGS
TRY all inter-dependent → reduce by-products, increase rate and yield









C H O + 0.5 O  C H O + 2 CO + H O
>100 g/L
• BDO pathway involves 4 reduction steps – redox intensive
• BDO pathway generates 1 extra NAD(P)H and no excess ATP
• Balance energy, redox and maintain high NAD(P)H/NAD(P)+ ratio
• Microaerobic production (DO ≈ 0) required for optimal performance
ATP = 0
NAD(P)H = +1
Oxidative TCA cycle flux required for redox needs of BDO pathway
ATP via oxidative
phosphorylation
6 12 6 2 4 10 2 2 2
Max yield = 1 mol/mol (0.50 g/g, 67 C-mol %)












































• Prioritized pathways proceed through 4-hydroxybutyrate
• Downstream enzymes function on non-natural substrates
ALDCat2 ADH
Alternative routes
1. Developed enzyme assays and analytical methods for all metabolites
2. Screened libraries of gene candidates for each step – >100 in some cases
3. Demonstrated seven different functional BDO pathways in E. coli
Yim et al., Nature Chem. Biol., 2011





•13C-Flux analysis identified significant drain due to competing pathways
• Microarray analysis identified candidate genes involved in backflux
• Intracellular metabolite measurements indicated downstream bottleneck






















































• 30% increase in BDO, 3 fold 4-hydroxybutyrate
• Significant decrease in pyruvate, acetate, CO2
Deletion of Endogenous Alcohol Dehydrogenases
Sugar
KO all 4 ADHs
No Backflux
• Fractionation/proteomics 
• Deleted 4 ADH’s
• All 4 backflux ADH’s
NADP+-dependent
















Improving the Downstream Pathway: Cat2



















Enzyme Discovery - Bioinformatics Directed Enzyme Evolution













































1 ) New Cat2
Original Cat2’s
6x
Evolution increased rate of 033 2.5 X  in 1M BDO
2.5x
Improving the Downstream Pathway: ADH

















Screened over 200 ADH enzymes
14 fold 
increase
Evolved best ADH parent - 956
in kcat/KM
Improving the Downstream Pathway:  ALD



















• Combined discovery and evolution
• BDO productivity improved 8 fold
• Evolved ALD uses NADH and NADPH 







variants into the BDO 
production strain
RPU = RFP fluorescence of promoter 































































































































































































































































































































































































































































































































































Optimization of BDO Pathway Gene Expression









































Higher soluble acCve protein = higher BDO → not always strongest promoter
Lowering By-Products: γ-Butyrolactone (GBL)



















• GBL formed by cyclization of 4-HB-CoA (C-yield loss)
• GBL formation enzyme induced and spontaneous
• Enzymes identified by microarray experiments
Two approaches to eliminate GBL by-product:
1. Delete genes responsible for GBL
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Lowering By-Products: Excess CO2











• Excess CO2 from complete TCA 
• Delete sucCD gene – lose 1 ATP






















• 13C flux analysis demonstrates little oxidative TCA flux in ∆sucCD strain






Lowering Excess CO2 via sucCD Deletion
Parent Strain
∆sucCD Strain:  higher BDO, much lower CO2
BDO Scale-up and Commercialization
Joint Development Partnership with Tate & Lyle 
• $4.3B per year
• Operates four corn wet mills




Genomatica taking proven path:
 Same base organism
 Same scale-up factor
 Similar chemical
 Similar cost model
Demonstration
Commercial










in Decatur demo plant
Bio-BDO® Becoming a Commercial Reality
2008 2013












 Over 35 genetic manipulations
 Eliminated reverse C-flux
 Improved pathway enzymes
 Promoter libraries/expression tuning
 Eliminated/reduced by-products
 Fully integrated, constitutive strain
 Achieved commercial TRY targets
 Process scale-up to 13,000 L (1 ton/wk)
2011
108 g/L
1.2 M
Questions?
Thank you.
Mark Burk
mburk@genomatica.com 
